Live Breaking News & Updates on Amneal Pharmaceuticals Company Profile

Stay updated with breaking news from Amneal pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amneal Pharmaceuticals (NYSE:AMRX) Sets New 12-Month High at $5.85

Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as $5.85 and last traded at $5.78, with a volume of 84835 shares changing hands. The stock had previously closed at $5.76. Wall Street Analysts Forecast Growth AMRX has been the topic […] ....

United-states , American , Tower-research-capital , Amneal-pharmaceuticals-company-profile , News-ratings-for-amneal-pharmaceuticals-daily , Pricet-rowe-associates-inc , Grantham-mayo-van-otterloo-co , American-century-companies-inc , Amneal-pharmaceuticals-stock-performance , Amneal-pharmaceuticals-inc , Hedge-funds-weigh-in-on-amneal-pharmaceuticals

Truist Financial Reaffirms "Buy" Rating for Amneal Pharmaceuticals (NYSE:AMRX)

Truist Financial reaffirmed their buy rating on shares of Amneal Pharmaceuticals (NYSE:AMRX – Free Report) in a report released on Wednesday, Benzinga reports. The firm currently has a $6.00 target price on the stock. Other equities analysts also recently issued research reports about the company. Barclays increased their price target on Amneal Pharmaceuticals from $4.00 […] ....

United-states , Montreal , Quebec , Canada , American , Piper-sandler , Andrews-boyer , Amneal-pharmaceuticals-trading , Barclays , Grantham-mayo-van-otterloo-co , American-century-companies-inc , News-ratings-for-amneal-pharmaceuticals-daily

StockNews.com Begins Coverage on Amneal Pharmaceuticals (NYSE:AMRX)

StockNews.com Begins Coverage on Amneal Pharmaceuticals (NYSE:AMRX)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states , Montreal , Quebec , Canada , Hong-kong , American , Piper-sandler , Andrews-boyer , Intercept-hong-kong-ltd , Barclays , Analyst-recommendations-for-amneal-pharmaceuticals , Institutional-investors-weigh-in-on-amneal-pharmaceuticals

Amneal Pharmaceuticals (NYSE:AMRX) Price Target Raised to $5.00 at Piper Sandler

Amneal Pharmaceuticals (NYSE:AMRX – Free Report) had its price objective upped by Piper Sandler from $3.00 to $5.00 in a report published on Monday morning, Marketbeat.com reports. They currently have an overweight rating on the stock. Other equities analysts have also recently issued reports about the company. 500.com reissued a maintains rating on shares of […] ....

Switzerland , Swiss , Piper-sandler , Metlife-investment-management , Swiss-national-bank , News-ratings-for-amneal-pharmaceuticals-daily , York-mellon-corp , Barclays , Blackrock-inc , Amneal-pharmaceuticals-price-performance , Amneal-pharmaceuticals , Amneal-pharmaceuticals-company-profile

Amneal Pharmaceuticals (NYSE:AMRX) PT Raised to $6.00

Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) had its price objective boosted by analysts at Truist Financial from $4.00 to $6.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price target points to a potential upside of 42.01% from the […] ....

Montreal , Quebec , Canada , United-states , American , Piper-sandler , Mirabella-financial-services , American-century-companies-inc , Analyst-recommendations-for-amneal-pharmaceuticals , Amneal-pharmaceuticals-company-profile , Pricet-rowe-associates-inc , Barclays